{{Rsnum
|rsid=11653499
|Gene=RPTOR
|Chromosome=17
|position=80610503
|Orientation=plus
|GMAF=0.2718
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RPTOR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.7 | 39.8 | 50.4
| HCB | 7.3 | 39.4 | 53.3
| JPT | 8.0 | 43.4 | 48.7
| YRI | 8.2 | 36.1 | 55.8
| ASW | 5.3 | 29.8 | 64.9
| CHB | 7.3 | 39.4 | 53.3
| CHD | 7.3 | 34.9 | 57.8
| GIH | 6.9 | 41.6 | 51.5
| LWK | 4.5 | 26.4 | 69.1
| MEX | 0.0 | 29.3 | 70.7
| MKK | 9.0 | 43.6 | 47.4
| TSI | 12.7 | 43.1 | 44.1
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19875696
|Title=Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}